Welcome to LookChem.com Sign In|Join Free

CAS

  • or

53472-18-7

Post Buying Request

53472-18-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

53472-18-7 Usage

General Description

5-Bromo-Quinolin-8-Ylamine is a chemical compound that belongs to the class of organic compounds known as quinolines and derivatives. These are compounds containing a quinoline moiety, a two-ring aromatic system derived from benzene and pyridine through the fusion of an imidazole ring at the benzene moiety. It is also identified as an aromatic amine, which consists of an amine attached to an aromatic hydrocarbon. 5-Bromo-Quinolin-8-Ylamine is used mainly in chemical synthesis and pharmaceutical research mostly due to its distinctive structure, displaying properties of both amine and aromatic groups. While little information is available about its direct applications, typically molecules like this are used as intermediate compounds for creating new, more complex molecules.

Check Digit Verification of cas no

The CAS Registry Mumber 53472-18-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,4,7 and 2 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 53472-18:
(7*5)+(6*3)+(5*4)+(4*7)+(3*2)+(2*1)+(1*8)=117
117 % 10 = 7
So 53472-18-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H7BrN2/c10-7-3-4-8(11)9-6(7)2-1-5-12-9/h1-5H,11H2

53472-18-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-bromoquinolin-8-amine

1.2 Other means of identification

Product number -
Other names 5-Bromo-8-aminochinolin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:53472-18-7 SDS

53472-18-7Relevant articles and documents

Merging Photoredox Catalysis with Iron(III) Catalysis: C5-H Bromination and Iodination of 8-Aminoquinoline Amides in Water

Qiao, Huijie,Sun, Suyan,Yang, Fan,Zhu, Yu,Kang, Jianxun,Wu, Yusheng,Wu, Yangjie

, p. 1976 - 1980 (2017)

A simple and efficient protocol for the iron(III)-catalyzed C5 halogenation of 8-aminoquinoline with potassium halides via a photoredox process was developed, affording desired products in good to excellent yields. This reaction features its mild and gree

Visible light-induced mono-bromination of arenes with BrCCl3

Fan, Jiali,Wei, Qiancheng,Zhu, Ershu,Gao, Jing,Cheng, Xiamin,Lu, Yongna,Loh, Teck-Peng

supporting information, p. 5977 - 5980 (2021/06/18)

A highly efficient and regioselective bromination of electron-rich arenes and heteroarenes using commercially available BrCCl3as a “Br” source has been developed. The reaction was performed in air under mild conditions with photocatalyst Ru(bpy)3Cl2·6H2O, avoiding the usage of strong acids and strong oxidants. Mono-brominated products were obtained with medium to excellent yields (up to 94%). This strategy has shown good compatibility and highpara-selectivity, which will facilitate the complicated synthesis.

New compound used as rearranged during transfection kinase inhibitor

-

, (2021/03/05)

The present invention relates to a compound, a pharmaceutical composition containing the compound, a preparation method of the compounds, and application of the same as a rearranged during transfection (RET) kinase inhibitor. The compound is a compound shown as formula (I), or a pharmaceutically acceptable salt, a prodrug, a solvent compound, a polymorph, an isomer and a stable isotope derivativethereof. The present invention also relates to the application of the compounds to treatment or prevention of RET kinase mediated related diseases like tumors and a method of using the compounds for the treatment of the diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 53472-18-7